Valbiotis SAS (ALVAL) - Total Liabilities

Latest as of June 2025: €8.14 Million EUR ≈ $9.52 Million USD

Based on the latest financial reports, Valbiotis SAS (ALVAL) has total liabilities worth €8.14 Million EUR (≈ $9.52 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ALVAL cash flow metrics to assess how effectively this company generates cash.

Valbiotis SAS - Total Liabilities Trend (2015–2024)

This chart illustrates how Valbiotis SAS's total liabilities have evolved over time, based on quarterly financial data. Check Valbiotis SAS (ALVAL) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Valbiotis SAS Competitors by Total Liabilities

The table below lists competitors of Valbiotis SAS ranked by their total liabilities.

Company	Country	Total Liabilities
Delignit AG XETRA:DLX	Germany	€11.62 Million
Nova EYE Medical Ltd AU:EYE	Australia	AU$7.85 Million
Sakthi Sugars Limited NSE:SAKHTISUG	India	Rs13.20 Billion
Powercom Co Ltd TW:3043	Taiwan	NT$932.65 Million
Step One Clothing Ltd AU:STP	Australia	AU$10.13 Million
Firebird Metals Ltd AU:FRB	Australia	AU$784.06K
LQwD FinTech Corp V:LQWD	Canada	CA$42.45K
Inventec Besta Co Ltd TW:8201	Taiwan	NT$176.56 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Valbiotis SAS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ALVAL stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.43	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	1.06	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.69	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.41	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Valbiotis SAS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Valbiotis SAS (2015–2024)

The table below shows the annual total liabilities of Valbiotis SAS from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	€9.24 Million ≈ $10.80 Million	-32.62%
2023-12-31	€13.71 Million ≈ $16.03 Million	-1.08%
2022-12-31	€13.86 Million ≈ $16.20 Million	-2.72%
2021-12-31	€14.25 Million ≈ $16.66 Million	+2.29%
2020-12-31	€13.93 Million ≈ $16.28 Million	+104.63%
2019-12-31	€6.81 Million ≈ $7.96 Million	+51.35%
2018-12-31	€4.50 Million ≈ $5.26 Million	+76.15%
2017-12-31	€2.55 Million ≈ $2.98 Million	+103.43%
2016-12-31	€1.25 Million ≈ $1.47 Million	+16.31%
2015-12-31	€1.08 Million ≈ $1.26 Million	--

About Valbiotis SAS

PA:ALVAL France Packaged Foods

Market Cap

$25.61 Million

€21.91 Million EUR

Market Cap Rank

#24293 Global

#396 in France

Share Price

€0.93

Change (1 day)

-0.54%

52-Week Range

€0.55 - €1.23

All Time High

€10.54